Trial Profile
Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease: a Feasibility Trial
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 10 Oct 2018
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Sickle cell anaemia
- Focus Therapeutic Use
- 28 Sep 2018 Status changed from recruiting to withdrawn prior to enrolment.
- 14 Nov 2016 New trial record